enow.com Web Search

  1. Ad

    related to: why is vascepa so expensive

Search results

  1. Results from the WOW.Com Content Network
  2. Ethyl eicosapentaenoic acid - Wikipedia

    en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

    Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia [4] and hypertriglyceridemia. [3] It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150 mg/dL.

  3. Prescription drug prices in the United States - Wikipedia

    en.wikipedia.org/wiki/Prescription_drug_prices...

    The price of a new drug (in most cases) is limited so that the cost of therapy with the new drug is in the range of the costs of therapy with existing drugs in the same therapeutic class. The price of a breakthrough drug is limited to the median of its prices in France, Germany, Italy, Sweden, Switzerland, Britain, and the United States.

  4. What Might Amarin Be Worth to GlaxoSmithKline or Others? - AOL

    www.aol.com/news/2013-10-25-what-might-amarin-be...

    Amarin shares have been beaten to a pulp, down more than 80% since getting Food and Drug Administration approval for its fish oil drug Vascepa back in July 2012. An FDA advisory panel recently ...

  5. Medicare's $2,000 prescription drug cap expected to bring ...

    www.aol.com/medicare-2-000-prescription-drug...

    Starting Jan. 1, older adults on Medicare will spend no more than $2,000 a year on prescription drugs when a new price cap on out-of-pocket payments from the Inflation Reduction Act goes into effect.

  6. Fish oil - Wikipedia

    en.wikipedia.org/wiki/Fish_oil

    As of 2019, the US Food and Drug Administration (FDA) has approved four fish oil-based prescription drugs, namely Lovaza, Omtryg (both omega-3-acid ethyl esters), Vascepa (ethyl eicosapentaenoic acid), and Epanova (omega-3-carboxylic acids). [8] None of these drugs are actually fish oil; they are all derivatives of acids found in fish oil.

  7. Dense Fog Over Amarin's Earnings - AOL

    www.aol.com/2013/03/01/dense-fog-over-amarins...

    It's been seven months since Amarin gained Food and Drug Administration approval of its lipid-lowering drug, Vascepa, so it's understandable that investors may have been a little itchy for some ...

  8. Investigators to Present New REDUCE-IT Subanalysis of VASCEPA ...

    lite.aol.com/tech/story/0022/20241111/9270771.htm

    DUBLIN and BRIDGEWATER, N.J., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that investigators will present an additional subgroup analysis from the landmark REDUCE-IT outcomes trial in patients with and without coronary artery disease (CAD) history and mechanistic data on eicosapentaenoic acid (EPA) at the American Heart Association’s Scientific ...

  9. America’s Most Admired Lawbreaker - The Huffington Post

    highline.huffingtonpost.com/miracleindustry/...

    The bank account, he was told, was meant to cover travel expenses for health department officials so that they could examine a program that their colleagues in Texas had told them about. It seemed like a promising way to create modern prescription guidelines for Pennsylvania’s use of antipsychotic drugs in state mental institutions and among ...

  1. Ad

    related to: why is vascepa so expensive